1.
de Weerdt I, Koopmans SM, Kater AP, van Gelder M. Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach. Haematologica [Internet]. 2017Sep.30 [cited 2026Nov.14];102(10):1629-3. Available from: https://haematologica.org/article/view/8211